Explore how future pharma will personalize medicine—customizing drugs by mood and genetics. Discover opportunities, challenges, expert views, and real-world examples.

Who should control the power of CRISPR? This article explores global legal frameworks, ethical debates, and regulatory battles shaping the future of gene editing.

It all begins with an idea.

DNA-based data storage could someday hold not just information, but even questions of identity — are we heading toward downloadable souls?

CRISPR therapies like Casgevy offer cures for genetic diseases — but who gets access? An urgent call for equity in the age of gene editing.

Should humans be genetically engineered to survive Mars? Explore the real science and bioethics behind CRISPR and NASA’s quest for off-world adaptation.

Explore how genetic testing—edited or unedited—could impact insurance rates, workplace opportunities, and personal relationships as privacy and discrimination debates intensify.

Playful exploration of nutrigenomics, where food talks to your DNA and the future of eating could be driven by epigenetics and gene-based diets.

Business analysis examining how GM foods could address global

food security, malnutrition, and health challenges. Explores biotech market

opportunities, genomic innovations, and regulatory barriers in agricultural

biotechnology.

Scientists are engineering microbes to digest plastic waste. Could this biotech breakthrough revolutionize ocean cleanup and reshape recycling?

Sickle cell disease has long been one of medicine’s most painful paradoxes — a single-gene mutation that wreaks lifelong havoc on millions yet has remained stubbornly incurable.

Artificial womb technology is advancing. Explore how gestational biobags could reshape neonatal care, parenthood, abortion debates, and bioethics.

Discover how genetic engineering is paving the way for the first de-extinction zoo, with Colossal Biosciences leading the charge to revive extinct animals and create a modern Jurassic Park.